[go: up one dir, main page]

NO20081934L - Diaryleterderivater som antitumor midler - Google Patents

Diaryleterderivater som antitumor midler

Info

Publication number
NO20081934L
NO20081934L NO20081934A NO20081934A NO20081934L NO 20081934 L NO20081934 L NO 20081934L NO 20081934 A NO20081934 A NO 20081934A NO 20081934 A NO20081934 A NO 20081934A NO 20081934 L NO20081934 L NO 20081934L
Authority
NO
Norway
Prior art keywords
group
formula
antitumor agents
ether derivatives
hydrogen atom
Prior art date
Application number
NO20081934A
Other languages
English (en)
Norwegian (no)
Inventor
Takashi Nakagawa
Hironori Matsuyama
Kenji Ohnishi
Hideki Takasu
Makoto Sakamoto
Kumi Higuchi
Keisuke Miyajima
Satoshi Yamada
Masaaki Motoyama
Yutaka Kojima
Koichi Yasumura
Takeshi Kodama
Shun Otsuji
Keizo Kan
Takumi Sumida
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NO20081934L publication Critical patent/NO20081934L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20081934A 2005-12-05 2008-04-23 Diaryleterderivater som antitumor midler NO20081934L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005351255 2005-12-05
PCT/JP2006/324610 WO2007066784A2 (fr) 2005-12-05 2006-12-04 Substance medicamenteuse

Publications (1)

Publication Number Publication Date
NO20081934L true NO20081934L (no) 2008-08-13

Family

ID=38051953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081934A NO20081934L (no) 2005-12-05 2008-04-23 Diaryleterderivater som antitumor midler

Country Status (21)

Country Link
US (1) US8236826B2 (fr)
EP (1) EP1957073B1 (fr)
KR (1) KR101157004B1 (fr)
CN (1) CN101321529B (fr)
AR (1) AR056885A1 (fr)
AU (1) AU2006323700B2 (fr)
BR (1) BRPI0619349A2 (fr)
CA (1) CA2630468C (fr)
CY (1) CY1115171T1 (fr)
DK (1) DK1957073T3 (fr)
ES (1) ES2463450T3 (fr)
IL (1) IL191544A0 (fr)
MY (1) MY146514A (fr)
NO (1) NO20081934L (fr)
PL (1) PL1957073T3 (fr)
PT (1) PT1957073E (fr)
RU (1) RU2444362C2 (fr)
SI (1) SI1957073T1 (fr)
TW (1) TWI332838B (fr)
WO (1) WO2007066784A2 (fr)
ZA (1) ZA200804445B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100927563B1 (ko) 2004-08-06 2009-11-23 오쓰까 세이야꾸 가부시키가이샤 방향족 화합물
UA95978C2 (ru) * 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
CN101597278B (zh) 2008-06-04 2013-04-17 中国中化股份有限公司 酰胺类化合物及其制备与应用
US8927549B2 (en) 2008-11-21 2015-01-06 High Point Pharmaceuticals, Llc Adamantyl benzamide derivatives
BRPI1015096A2 (pt) 2009-04-20 2016-05-03 Mitsubishi Tanabe Pharma Corp agonista de receptor beta de hormônio tireoideano
JP5758395B2 (ja) 2009-10-15 2015-08-05 ザ チルドレンズ メディカル センター コーポレイション 疼痛を治療するためのセピアプテリンレダクターゼ阻害薬
EP2528897B9 (fr) * 2010-01-29 2015-04-22 Otsuka Pharmaceutical Co., Ltd. Dérivés de pyridine di-substitués comme agents anticancéreux
WO2012015715A1 (fr) 2010-07-27 2012-02-02 High Point Pharmaceuticals, Llc Dérivés de thiazol-2-ylamine substitués, compositions pharmaceutiques et procédés d'utilisation en tant que modulateurs de 11-bêta-hsd1
JP5715690B2 (ja) 2010-10-04 2015-05-13 大塚製薬株式会社 複素環式化合物
WO2012090177A2 (fr) * 2010-12-30 2012-07-05 Lupin Limited Modulateurs des récepteurs cannabinoïdes
IN2014MN00226A (fr) * 2011-07-05 2015-09-25 Lupin Ltd
TW201329025A (zh) 2011-11-01 2013-07-16 Astex Therapeutics Ltd 醫藥化合物
US9376376B2 (en) 2012-03-14 2016-06-28 Sinochem Corporation Substitute diphenylamine compounds use thereof as antitumor agents
JP6066806B2 (ja) * 2012-04-03 2017-01-25 大塚製薬株式会社 医薬
TWI567068B (zh) 2013-02-19 2017-01-21 小野藥品工業股份有限公司 Ｔｒｋ抑制化合物
PL3043784T3 (pl) * 2013-09-09 2019-10-31 Peloton Therapeutics Inc Etery arylowe i ich zastosowania
WO2015179414A1 (fr) * 2014-05-19 2015-11-26 Merial, Inc. Composés anthelmintiques
TW201617314A (zh) * 2014-09-10 2016-05-16 第一三共股份有限公司 羧酸衍生物
CN107098884A (zh) * 2016-02-19 2017-08-29 中国科学院上海药物研究所 一类取代的氨基吡啶类化合物及其制备和用途
JP7444458B2 (ja) * 2018-09-21 2024-03-06 学校法人福岡大学 プリオン病治療薬
KR20240156627A (ko) * 2022-02-28 2024-10-30 시로낙스 엘티디 Rip1 조절자, 이의 제조 및 용도

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629102A (fr) * 1961-03-29
NL7111711A (fr) 1970-09-17 1972-03-21
US3715375A (en) * 1970-09-17 1973-02-06 Merck & Co Inc New diphenyl sulfones
GB1494117A (en) 1974-11-02 1977-12-07 Bayer Ag Process for the preparation of acid amides
DE2707659A1 (de) * 1977-02-23 1978-08-24 Bayer Ag Selbstvernetzbare polyurethane
DE2707660C2 (de) * 1977-02-23 1985-12-19 Bayer Ag, 5090 Leverkusen Abspalter- und Diolrest enthaltende Diisocyanat-Addukte, ihre Herstellung und Verwendung
DE2812252A1 (de) * 1978-03-21 1979-10-04 Bayer Ag 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
EP0500495A3 (en) * 1991-02-21 1993-04-07 Ciba-Geigy Ag Thermosetting composition
DE69314718T2 (de) 1992-07-21 1998-02-26 Ciba Geigy Ag Oxamidsäure-Derivate als hypocholesterämische Mittel
WO1995001326A1 (fr) 1993-06-30 1995-01-12 The Wellcome Foundation Limited Composes de diaryle contre l'atherosclerose
CA2223948A1 (fr) 1995-06-07 1996-12-19 Rui Han Retinoides de chalcone et leurs procedes d'utilisation
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
AU2723099A (en) 1998-02-06 1999-08-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors
ATE282607T1 (de) 1998-02-06 2004-12-15 Max Planck Gesellschaft Tryptase-inhibitoren
AR015733A1 (es) 1998-03-25 2001-05-16 Otsuka Pharma Co Ltd DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO.
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
WO2000005198A1 (fr) * 1998-07-24 2000-02-03 Teijin Limited Derives d'acide anthranilique
US20020065296A1 (en) * 1999-01-13 2002-05-30 Bayer Corporation Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
EP1140840B1 (fr) * 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. Diphenylurees a substituants -g(v)-carboxyaryles, inhibitrices de kinase raf
AU2871900A (en) 1999-02-04 2000-08-25 Millennium Pharmaceuticals, Inc. G-protein coupled heptahelical receptor binding compounds and methods of use thereof
CO5160290A1 (es) 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
US6159694A (en) * 1999-04-08 2000-12-12 Isis Pharmaceuticals Inc. Antisense modulation of stat3 expression
CN1372548A (zh) 1999-07-01 2002-10-02 味之素株式会社 杂环化合物及其医药用途
JP2001089412A (ja) 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩
JP2001089450A (ja) 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ピリジン誘導体含有医薬製剤
EP1256341A4 (fr) * 2000-02-15 2004-12-08 Teijin Ltd Medicament anticancereux comprenant un derive d'acide anthranilique en tant qu'ingredient actif
HU227630B1 (hu) 2000-05-22 2011-10-28 Aventis Pharma Inc Arilmetilamin-származékok triptáz gátlóként való alkalmazásra és ezeket tartalmazó gyógyszerkészítmények
GB0015205D0 (en) 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
EP1381603A2 (fr) 2000-08-18 2004-01-21 PHARMACIA & UPJOHN COMPANY Composes aryliques substitues par quinuclidine destines au traitement de maladies (ligands du recepteur nicotinique de l'acetylcholine)
IL155097A0 (en) 2000-09-28 2003-10-31 Nanocyte Inc Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
AU2002223626A1 (en) 2000-10-20 2002-04-29 Novartis Ag Combinations of a thyromimetic compound and a statin
EP1211235A3 (fr) 2000-11-30 2004-01-02 JFE Chemical Corporation Procédé de préparation d'éthers d'acide diphényldicarboxylique et ses dérivés
JP2004269356A (ja) 2000-12-27 2004-09-30 Ajinomoto Co Inc 創傷部癒着防止剤
GB2374009A (en) 2001-02-12 2002-10-09 Novartis Ag Method of treating hair loss
HRP20030834A2 (en) 2001-06-20 2004-08-31 Pfizer Prod Inc Novel sulfonic acid derivatives
WO2003018586A1 (fr) 2001-08-24 2003-03-06 Pharmacia & Upjohn Company Aryl 7-aza[2.2.1]bicycloheptanes substitues utiles dans le traitement de maladies
ES2337241T3 (es) 2001-10-22 2010-04-22 Pfizer Products Inc. Derivados de piperazina con actividad antagonista de receptores ccr1.
WO2003035602A1 (fr) 2001-10-25 2003-05-01 Sankyo Company, Limited Modulateurs lipidiques
BR0307714A (pt) 2002-02-15 2005-02-09 Upjohn Co Benzoilamidas substituìdas com azabiciclo e tioamidas para tratamento de distúrbios relacionados ao cns
FR2836917B1 (fr) 2002-03-11 2006-02-24 Lipha Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
JP2004035475A (ja) 2002-07-03 2004-02-05 Ajinomoto Co Inc ＴＧＦβ作用抑制剤
NZ542304A (en) * 2003-03-14 2009-07-31 Ono Pharmaceutical Co Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
WO2005007621A2 (fr) 2003-05-30 2005-01-27 Rigel Pharmaceuticals, Inc. Inhibiteurs de ligase d'ubiquitine
PT1658263E (pt) * 2003-07-24 2010-09-06 Leo Pharma As Novos compostos de aminobenzofenona
KR100927563B1 (ko) * 2004-08-06 2009-11-23 오쓰까 세이야꾸 가부시키가이샤 방향족 화합물
UA95978C2 (ru) * 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
TWI440638B (zh) * 2007-10-30 2014-06-11 Otsuka Pharma Co Ltd 雜環化合物及其藥學組成物

Also Published As

Publication number Publication date
RU2444362C2 (ru) 2012-03-10
CA2630468C (fr) 2015-01-20
IL191544A0 (en) 2008-12-29
WO2007066784A2 (fr) 2007-06-14
AU2006323700B2 (en) 2011-02-17
HK1123219A1 (en) 2009-06-12
ZA200804445B (en) 2009-11-25
KR101157004B1 (ko) 2012-07-09
AU2006323700A1 (en) 2007-06-14
AR056885A1 (es) 2007-10-31
BRPI0619349A2 (pt) 2011-11-08
EP1957073A2 (fr) 2008-08-20
EP1957073B1 (fr) 2014-04-23
KR20080070054A (ko) 2008-07-29
MY146514A (en) 2012-08-15
DK1957073T3 (da) 2014-05-12
ES2463450T3 (es) 2014-05-28
TW200800200A (en) 2008-01-01
US8236826B2 (en) 2012-08-07
TWI332838B (en) 2010-11-11
RU2008127325A (ru) 2010-01-20
CY1115171T1 (el) 2016-12-14
CN101321529A (zh) 2008-12-10
US20100004438A1 (en) 2010-01-07
CA2630468A1 (fr) 2007-06-14
WO2007066784A3 (fr) 2007-10-25
PL1957073T3 (pl) 2014-09-30
CN101321529B (zh) 2012-09-05
PT1957073E (pt) 2014-05-12
SI1957073T1 (sl) 2014-08-29

Similar Documents

Publication Publication Date Title
NO20081934L (no) Diaryleterderivater som antitumor midler
NO20090856L (no) STAT3/5 activeringsinhibitor
TW200619214A (en) Aromatic compound
DK1270584T3 (da) Glucopyranosyloxybenzylbenzenderivater, medicinske sammensætninger indeholdende samme og intermediater til fremstilling af derivaterne
MY142807A (en) Benzimidazole derivative and use thereof.
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
TW200745034A (en) New compounds
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
NO20085240L (no) C-fenyl-1-tioglucitolforbindelse
NZ602099A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DE602006007012D1 (de) Pyridinderivate als dipeptedyl-peptidase-hemmer
MXPA05003193A (es) Compuesto de adenina novedoso y uso del mismo.
MD20110063A2 (en) Herbicidal compositions containing benzoylpyrazole compounds
MY144588A (en) Novel coumarin derivative having antitumor activity
TW200730514A (en) Morpholine type cinnamide compound
BRPI0407283A (pt) Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade
NO20083520L (no) Tricykliske N-heteroaryl-karboksamidderivater inneholdende en benzimidazolenhet, fremgangsmate for fremstilling av samme og deres terapeutiske anvendelser
EP1396493A4 (fr) Composes heterocycliques
MY139461A (en) Condensed furan compounds
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
TW200420292A (en) Benzofuran derivative
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
TW200714593A (en) Agent for treatment of solid tumor
TW200720265A (en) Agent for treatment of hematopoietic tumor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application